Table 4 Characteristics of the participants with diabetes and those in each quartile group for urate
1st quartile Urate: 0.8–4.7 mg/dl | 2nd quartile Urate: 4.8–5.5 mg/dl | 3rd quartile Urate: 5.6–6.4 mg/dl | 4th quartile Urate: 6.5–12.9 mg/dl | Overall Urate: 0.8–12.9 mg/dl | |
|---|---|---|---|---|---|
Number | 190 | 202 | 224 | 186 | 802 |
Urate (mg/dl) | 3.90 ± 0.73 | 5.17 ± 0.23** | 6.00 ± 0.24** | 7.31 ± 0.83** | 5.59 ± 1.33 |
Age (years) | 54.2 ± 7.8 | 53.6 ± 7.7 | 53.2 ± 7.9 | 51.7 ± 8.1* | 53.2 ± 7.9 |
Smokers (%) | 47.4 | 51.5 | 52.9 | 49.5 | 50.4 |
Drinkers (%) | |||||
Occasional | 33.2 | 37.6 | 37.9 | 39.8 | 37.2 |
Regular | 38.4 | 36.1 | 42.4 | 43.0 | 40.0 |
Regular exercise (%) | 19.5 | 13.9 | 12.9 | 15.1 | 15.2 |
Height (cm) | 168.6 ± 6.6 | 168.1 ± 6.3 | 168.4 ± 5.9 | 169.4 ± 6.3 | 168.6 ± 6.3 |
Body weight (kg) | 70.3 ± 12.4 | 72.1 ± 14.0 | 72.1 ± 12.6 | 75.8 ± 13.6** | 72.5 ± 13.3 |
Waist circumference (cm) | 86.7 ± 9.2 | 88.0 ± 10.7 | 87.9 ± 9.7 | 90.3 ± 9.9** | 88.2 ± 9.9 |
Body mass index (kg/m2) | 24.6 ± 3.6 | 25.4 ± 4.4 | 25.3 ± 3.8 | 26.3 ± 4.1** | 25.4 ± 4.0 |
Triglycerides (mg/dl) | 99 (65, 165) | 122 (76, 190) | 127 (84, 209) | 137 (94, 219)** | 122 (79, 194) |
Therapy for hypertension (%) | 24.7 | 35.1* | 33.5 | 40.3** | 33.4 |
Therapy for dyslipidemia (%) | 14.2 | 19.8 | 17.4 | 21.0 | 18.1 |
Therapy for diabetes (%) | 58.4 | 62.9 | 62.1 | 61.3 | 61.2 |
High WHtR (%) | 62.6 | 64.9 | 66.1 | 69.4 | 65.7 |
Hypertension (%) | 46.8 | 54.5 | 53.6 | 63.4** | 54.5 |
Hyper-triglyceridemia (%) | 30.5 | 37.1 | 37.9 | 43.5* | 37.3 |
Hypo-HDL cholesterolemia (%) | 11.1 | 17.8 | 14.7 | 18.8* | 15.6 |
Dyslipidemia (%) | 45.3 | 56.4* | 51.3 | 57.5* | 52.6 |
Metabolic syndrome (%) | 50.5 | 56.9 | 53.6 | 60.2 | 55.2 |